Patents by Inventor Carroll Wayne Ours

Carroll Wayne Ours has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diacylated derivatives of .gamma.-glutamyl dopamine
    Patent number: 4031242
    Abstract: This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.
    Type: Grant
    Filed: September 11, 1975
    Date of Patent: June 21, 1977
    Assignee: Abbott Laboratories
    Inventors: Peter Hadley Jones, Carroll Wayne Ours, Jaroslav Kyncl
  • Esters of .gamma.-glutamyl amide of dopamine
    Patent number: 4017636
    Abstract: Covers the esters of .gamma.-glutamyl amide of dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.18 alkyl radical, and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said esters of .gamma.-glutamyl amide of dopamine to increase renal blood flow by administering said amide to warm-blooded mammals by clinically acceptable routes of administration such as oral, parenteral, rectal, etc.
    Type: Grant
    Filed: September 24, 1975
    Date of Patent: April 12, 1977
    Assignee: Abbott Laboratories
    Inventors: Peter Hadley Jones, Jaroslav Kyncl, Carroll Wayne Ours, Pitambar Somani
  • Compositions and methods of increasing renal blood flow with gamma-glutamyl amide of dopamine
    Patent number: 3947590
    Abstract: Covers a .gamma.-glutamyl amide of dopamine selected from the group consisting of ##EQU1## and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said .gamma.-glutamyl amide to increase renal blood flow by administering said amide to warm-blooded mammals.
    Type: Grant
    Filed: January 27, 1975
    Date of Patent: March 30, 1976
    Assignee: Abbott Laboratories
    Inventors: Jaroslav Kyncl, Kathleen Riley Lynn, Yvonne Connolly Martin, Carroll Wayne Ours